Bladder cancer management has seen big changes in the last several years. Immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs) have significantly improved outcomes, and their use has recently expanded into the perioperative setting for muscle-invasive bladder cancer (MIBC). Additionally, biomarkers such as circulating tumor DNA (ctDNA) are making possible the increasing personalization of treatment a boon to patients but a challenge to clinicians. In this activity, experts discuss the emerging role of ctDNA and the importance of a multidisciplinary team approach to MIBC management.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Child & Adolescent Psychiatry
- Clinical Informatics
- Communication & Shared Decision-Making
- Comprehensive & Board Review
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Foot & Ankle Surgery
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Infectious Disease
- Laryngology
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Infectious Diseases
- Pediatric Neurology
- Practice Management & Ethics
- Primary Care Sports Medicine
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Transplant Hepatology
- Transplant Surgery
- Vascular Neurology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
- Enduring / On-demand
- Credit · Up to 0.5 credits
- MOC · Up to 0.5 points
- Commercial Support
-
ReleasedMay 27, 2026
-
Last day to claim creditMay 28, 2027 8 months left
-
Learner’s Digest International (TM) Bladder, Kidney, and Prostate Cancers
-
World Bladder Cancer Patient Coalition +1 Bladder Cancer Breakthroughs Unpacked: Practical Guidance on Bladder-Sparing Innovations, Perioperative Standards, and Multi-Targeted Platforms Across the Disease Spectrum
-
PRIME Education, Inc. (PRIME®) Elevating Bladder Cancer Outcomes Through Evidence-Based, Multidisciplinary Care
-
RedMedEd +1 Novel Therapies for Perioperative Management of Muscle-Invasive Bladder Cancer
-
Efficient LLC +1 What Gets Under Patients Skin: Integrating Subcutaneous Immune Checkpoint Inhibitor Formulations into the Management of Solid Tumors in Oncology Practice
-
MedAll +1 Evolving Paradigms in Lung Cancer: Module 4 Decision Trees for Patient Selection and Monitoring
